UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2020 | 2022-11-14 | Future report Set alerts | |
| Q2 2020 | 2022-09-08 | 0.00 | 0.00 |
| Q1 2020 | 2022-05-23 | -0.16 | -0.16 |
| Q4 2019 | 2022-04-06 | -0.18 | -0.18 |
| Q3 2019 | 2021-11-15 | 0.03 | 0.03 |
| Q2 2019 | 2021-08-16 | -0.14 | -0.14 |
| Q1 2019 | 2021-05-12 | 0.19 | 0.19 |
| Q4 2018 | 2021-03-29 | 0.00 | 0.00 |
| Q3 2018 | 2018-11-13 | -2.42 | -2.42 |
| 2016-06-06 | Initiated Coverage | Roth Capital | Buy | $1.20 |
| 2016-05-24 | Reiterated Rating | Rodman & Renshaw | Buy | |
| 2016-05-13 | Downgrade | Feltl & Co. | Strong-Buy to Buy | |
| 2016-03-31 | Reiterated Rating | Rodman & Renshaw | Buy | |
| 2016-03-23 | Reiterated Rating | Rodman & Renshaw | Buy | $4.00 |
| 2016-03-14 | Reiterated Rating | Rodman & Renshaw | Buy | |
| 2016-01-10 | Reiterated Rating | HC Wainwright | Buy | $4.00 |
| 2016-01-10 | Reiterated Rating | Rodman & Renshaw | Buy | |
| 2015-08-19 | Initiated Coverage | HC Wainwright | Buy | $4.00 |
| 2015-01-21 | Reiterated Rating | Aegis | Buy | |
| 2014-06-03 | Initiated | Aegis Capital | Buy | $16 |
| 2014-06-03 | Initiated Coverage | Aegis | Buy | $16.00 |
| 2014-05-01 | Initiated Coverage | Feltl & Co. | Strong-Buy |
| 2016-06-06 | Initiated Coverage | Roth Capital | Buy | $1.20 |
| 2016-05-24 | Reiterated Rating | Rodman & Renshaw | Buy | |
| 2016-05-13 | Downgrade | Feltl & Co. | Strong-Buy to Buy | |
| 2016-03-31 | Reiterated Rating | Rodman & Renshaw | Buy | |
| 2016-03-23 | Reiterated Rating | Rodman & Renshaw | Buy | $4.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In BIOC 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| PITLER DAVID EVP & President BioImaging Svc | 0.31% (48800) | BIOC / |
| STACK DAVID M | 0.30% (46500) | BIOC / PCRX / |
UM